We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA recently issued a public health notice on the instructions for cleaning and sanitizing, or "reprocessing," ultrasound transducer assemblies used in biopsy procedures.
Frost & Sullivan has awarded its 2006 Actuator Technology Product Innovation of the Year Award to Artificial Muscle (AMI), for the development of the Universal Muscle Actuator (UMA).
Medical devices group Bespak posted a hike in profits as it benefited from the approval of its diabetes inhaler drug and an increase in sales following the acquisition of King Systems.
The U.S. Federal Drug Administration (FDA) announced a 510(k) pre-market clearance for Leksell GammaPlan PFX, the treatment planning
system developed for Leksell Gamma Knife Perfexion.
Johnson & Johnson, a health care company, announced that on July 6, OrthoNeutrogena, a division of Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson company, has purchased privately held biotechnology company Colbar LifeScience Ltd., specializing in reconstructive medicine and tissue engineering.
Boston Scientific Corporation announced the U.S. launch of the newest version of its Radial Jaw Single-Use Biopsy Forceps, featuring more jaw volume and an improved jaw design compared to the
market-leading Radial Jaw 3 Forceps.
The global market for minimally invasive surgery (MIS) devices and instruments -- including catheters, balloons, stents and other devices used in minimally invasive angioplasty -- is expected to
grow from an estimated $12 billion in 2005 to $12.9 billion in 2006 and should reach $18.5 billion by 2011, according to a June report.
ESKA Implants was issued a May 16 warning letter for quality system (QS) and medical device reporting deficiencies that were uncovered during a November 2005 inspection of the company's Lubeck, Germany, facility.